Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
Future Microbiol ; 16: 211-219, 2021 03.
Artigo em Inglês | MEDLINE | ID: mdl-33595345

RESUMO

Aim: To study the behavior of Candida albicans in women with vulvovaginal candidiasis (VVC), recurrent VVC (RVVC) and asymptomatic (AS), regarding adhesion on HeLa cells and their ability to express secreted aspartic proteinases (SAP) genes, agglutinin-like sequence (ALS) genes and HWP1. Materials & methods: The adhesion of Candida albicans to HeLa cells was evaluated by colony-forming units, and the expressed genes were evaluated by qRT-PCR. Results: AS and VVC isolates showed greater ability to adhere HeLa cells when compared with RVVC isolate. Nevertheless, RVVC isolate exhibited upregulation of a large number of genes of ALS and SAP gene families and HWP1 gene. Conclusion: The results demonstrated that RVVC isolate expressed significantly important genes for invasion and yeast-host interactions.


Assuntos
Ácido Aspártico Proteases/metabolismo , Candida albicans/genética , Candidíase Vulvovaginal/microbiologia , Ácido Aspártico Proteases/genética , Candida albicans/enzimologia , Candida albicans/crescimento & desenvolvimento , Colo do Útero/microbiologia , Feminino , Proteínas Fúngicas/genética , Proteínas Fúngicas/metabolismo , Regulação Fúngica da Expressão Gênica , Células HeLa , Humanos
2.
Future Microbiol ; 15: 1001-1013, 2020 07.
Artigo em Inglês | MEDLINE | ID: mdl-32811174

RESUMO

Aim: To compare the pathogenesis of vulvovaginal candidiasis by three Candida species in diabetic mice. Materials & methods: Estrogenized and diabetic mice were challenged with C. albicans, C. tropicalis and C. glabrata. Results: Diabetic animals infected with C. albicans and C. tropicalis maintained the highest fungal burden, despite of high levels of proinflammatory cytokines (IL-6 and TNF-α), respectively. For C. glabrata, the results were similar in diabetic and nondiabetic groups. Conclusion:C. tropicalis was as invasive as C. albicans, and both were more effective than C. glabrata. This ability was attributed to filamentation, which may be stimulated by glucose levels from vaginal fluid. In addition, the high burden may be attributed to the apparent immunological inefficiency of the diabetic host.


Assuntos
Candida albicans/fisiologia , Candida glabrata/fisiologia , Candida tropicalis/fisiologia , Candidíase Vulvovaginal/microbiologia , Complicações do Diabetes/microbiologia , Animais , Candida albicans/genética , Candida albicans/isolamento & purificação , Candida glabrata/genética , Candida glabrata/isolamento & purificação , Candida tropicalis/genética , Candida tropicalis/isolamento & purificação , Candidíase Vulvovaginal/etiologia , Candidíase Vulvovaginal/genética , Candidíase Vulvovaginal/metabolismo , Complicações do Diabetes/etiologia , Complicações do Diabetes/genética , Complicações do Diabetes/metabolismo , Modelos Animais de Doenças , Feminino , Humanos , Interleucina-6/genética , Interleucina-6/metabolismo , Camundongos , Fator de Necrose Tumoral alfa/genética , Fator de Necrose Tumoral alfa/metabolismo
3.
Future Microbiol ; 14: 519-531, 2019 04.
Artigo em Inglês | MEDLINE | ID: mdl-31033353

RESUMO

Aim: To evaluate the efficacy of photodynamic inactivation (PDI) mediated by hypericin encapsulated in P-123 copolymeric micelles (P123-Hyp) alone and in combination with fluconazole (FLU) against planktonic cells and biofilm formation of Candida species Materials & methods: PDI was performed using P123-Hyp and an LED device with irradiance of 3.0 mW/cm2 . Results: Most of isolates (70%) were completely inhibited with concentrations up to 2.0 µmol/l of HYP and light fluence of 16.2 J/cm2. FLU-resistant strains had synergic effect with P123-HYP-PDI and FLU. The biofilm formation was inhibited in all species, in additional the changes in Candida morphology observed by scanning electron microscopy. Conclusion: P123-Hyp-PDI is a promising option to treat fungal infections and medical devices to prevent biofilm formation and fungal spread.


Assuntos
Antifúngicos/farmacologia , Biofilmes/efeitos dos fármacos , Candida/efeitos dos fármacos , Micelas , Perileno/análogos & derivados , Antracenos , Biofilmes/crescimento & desenvolvimento , Biofilmes/efeitos da radiação , Candida/citologia , Candida/efeitos da radiação , Farmacorresistência Fúngica/efeitos dos fármacos , Sinergismo Farmacológico , Quimioterapia Combinada , Fluconazol/farmacologia , Humanos , Luz , Testes de Sensibilidade Microbiana , Microscopia Eletrônica de Varredura , Perileno/farmacologia , Fotoquimioterapia/métodos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA